Showing results (121-130 of 623) with videos related to
Sort By:
Pageof 63
Current Drug Delivery|August 11, 2010
Nanoparticles: a promising therapeutic approach in atherosclerosisCharalambos Antoniades, Costantinos Psarros, Dimitris Tousoulis, et al.The Journal of Invasive Cardiology|February 1, 2019
Successful Stent Delivery Through a Slaloming Coronary PathKonstantinos Aznaouridis, Maria Bonou, Konstantina Masoura, et al.Current Pharmaceutical Design|June 6, 2016
The Impact of Antiplatelet Treatment on Endothelial FunctionEmmanuel Androulakis, Karl Norrington, Constantinos Bakogiannis, et al.Biomedicines|April 27, 2024
MicroRNAs in Atrial Fibrillation: Mechanisms, Vascular Implications, and Therapeutic PotentialEmmanouil P Vardas, Panagiotis Theofilis, Evangelos Oikonomou, et al.Current Pharmaceutical Design|December 30, 2011
Potential pathogenic inflammatory mechanisms of endothelial dysfunction induced by type 2 diabetes mellitusAnna-Maria Kampoli, Dimitris Tousoulis, Alexandros Briasoulis, et al.Nature Clinical Practice. Cardiovascular Medicine|April 26, 2007
Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspectiveDimitris Tousoulis, Rainer H Böger, Charalambos Antoniades, et al.Biomedicines|February 25, 2022
Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand?Marios Sagris, Panagiotis Theofilis, Alexios S Antonopoulos, et al.Cardiovascular Research|June 5, 2019
The intestinal microbiota and cardiovascular diseaseThemistoklis Katsimichas, Alexios S Antonopoulos, Alexandros Katsimichas, et al.Cardiology in Review|August 20, 2009
Essential hypertension: is there a role for inflammatory mechanisms?Emmanuel S Androulakis, Dimitris Tousoulis, Nikolaos Papageorgiou, et al.Current Pharmaceutical Design|November 20, 2020
Heart Failure in Diabetes Mellitus: An Updated ReviewCatrin Sohrabi, Bunny Saberwal, Wei-Yao Lim, et al.Pageof 63